Histogenics Prices IPO Below Range

(RTTNews) - Histogenics Corp. said Tuesday that it has priced its underwritten initial public offering of about 5.91 million shares of its common stock at a price to the public of $11.00 per share.

The company previously planned to offer about 4.3 million shares at a price of $13.00 to $15.00 per share.

The shares are expected to begin trading on the NASDAQ Global Market under the ticker symbol "HSGX" on Wednesday, December 3.

Histogenics has granted the underwriters a 30-day option to purchase up to an additional 886,364 shares of its common stock to cover overallotments, if any, at the initial public offering price.

The net offering proceeds to Histogenics from the sale of the shares are expected to be about $57.2 million, after deducting underwriting discounts and commissions and estimated offering expenses, and excluding any exercise of the underwriters' overallotment option.

Cowen and Company, LLC, Needham & Company, LLC and Canaccord Genuity Inc. are acting as the joint book-running managers and BTIG, LLC is acting as co-manager for the offering.